Dr. Paul Sax wonders whether PrEP can be widely adopted, especially among those most at risk for acquiring HIV infection, in
HIV and ID Observations.
The CDC now recommends tenofovir/FTC (Truvada) for all Americans at high risk for acquiring HIV infection, particularly those with certain risk factors. Can pre-exposure prophylaxis be more broadly adopted? In his HIV and ID Observations blog, Dr. Paul Sax outlines some of the challenges.